Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Neurofilament accumulation disrupts autophagy in giant axonal neuropathy
Jean-Michel Paumier, … , Jeffrey N. Savas, Puneet Opal
Jean-Michel Paumier, … , Jeffrey N. Savas, Puneet Opal
Published March 10, 2025
Citation Information: JCI Insight. 2025;10(5):e177999. https://doi.org/10.1172/jci.insight.177999.
View: Text | PDF
Research Article Cell biology Neuroscience

Neurofilament accumulation disrupts autophagy in giant axonal neuropathy

  • Text
  • PDF
Abstract

Neurofilament accumulation is associated with many neurodegenerative diseases, but it is the primary pathology in giant axonal neuropathy (GAN). This childhood-onset autosomal recessive disease is caused by loss-of-function mutations in gigaxonin, the E3 adaptor protein that enables neurofilament degradation. Using a combination of genetic and RNA interference approaches, we found that dorsal root ganglia from mice lacking gigaxonin have impaired autophagy and lysosomal degradation through 2 mechanisms. First, neurofilament accumulations interfere with the distribution of autophagic organelles, impairing their maturation and fusion with lysosomes. Second, the accumulations attract the chaperone 14-3-3, which is responsible for the proper localization of the key autophagy regulator transcription factor EB (TFEB). We propose that this dual disruption of autophagy contributes to the pathogenesis of other neurodegenerative diseases involving neurofilament accumulations.

Authors

Jean-Michel Paumier, James Zewe, Chiranjit Panja, Melissa R. Pergande, Meghana Venkatesan, Eitan Israeli, Shikha Prasad, Natasha Snider, Jeffrey N. Savas, Puneet Opal

×

Figure 5

Lysosomal changes in GAN.

Options: View larger image (or click on image) Download as PowerPoint
Lysosomal changes in GAN.
(A) Representative live-imaging fluorescence i...
(A) Representative live-imaging fluorescence images of control and shGan cells from mouse DRG transduced with NFL-GFP tagged lentivirus and treated with red LysoTracker to visualize lysosomes. Expression of the NFL-GFP construct in shGan cells from mouse DRG neurons allowed neurofilament aggregate visualization in living cells. Scale bar: 30 μm. Insets are shown at ×3 magnification. (B and C) shGan induces an increase in the number of lysosomes and the surface area covered by these organelles. Note that as observed after NFL and LAMP-1 costaining, LysoTracker dye is also mainly excluded from neurofilament aggregates (circular dotted line). Quantitative data are presented as mean ± SEM. ***P < 0.001 by 2-tailed, unpaired Student’s t test. Representative images from 3 independent experiments.

Copyright © 2025 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts